NumFin

Cachet Pharmaceutical Co., Ltd.

Sümbol: 002462.SZ

SHZ

12.28

CNY

Turuhind täna

  • 14.3690

    P/E suhe

  • 0.7993

    PEG suhe

  • 3.58B

    MRK Cap

  • 0.02%

    DIV tootlus

Cachet Pharmaceutical Co., Ltd. (002462-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Cachet Pharmaceutical Co., Ltd. (002462.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 11542.929 M, mis on 0.248 % gowth. Kogu perioodi keskmine brutokasum on 1065.492 M, mis on 0.202 %. Keskmine brutokasumi suhtarv on 0.108 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.466 %, mis on võrdne 0.145 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Cachet Pharmaceutical Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.034. Käibevara valdkonnas on 002462.SZ aruandlusvaluutas 15630.535. Märkimisväärne osa neist varadest, täpsemalt 2885.601, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.321%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 1.743, kui neid on, aruandlusvaluutas. See näitab erinevust -23.531% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 175.946 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.060%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 4240.525 aruandlusvaluutas. Selle aspekti aastane muutus on 0.040%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 9187.408, varude hind on 2561.7 ja firmaväärtus 475.86, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 35.58. Kontovõlad ja lühiajalised võlad on vastavalt 5858.08 ja 3842.74. Koguvõlg on 4018.69, netovõlg on 1133.23. Muud lühiajalised kohustused moodustavad 52.98, mis lisandub kohustuste kogusummale 11029.34. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

10532.552885.62183.72338.4
2018.5
1576.5
1080.1
1124.3
796
537.2
449.1
303.4
384.4
512.9
465.5
212.5
176.1
96.8

balance-sheet.row.short-term-investments

0.590.10.20.2
-6.8
-7.1
2.8
-131.9
-141.1
-102.8
-38
0
0
0
144.4
0
0
0

balance-sheet.row.net-receivables

38852.379187.499488640.8
8440.3
7745.7
6783.8
5480
4298.8
3321.6
2459.2
1399.4
775.2
466.9
349.5
217.3
159.2
237.4

balance-sheet.row.inventory

10431.642561.72692.32185.4
2013.6
2253.3
1723.8
1336.1
1181
940.8
671
450.2
227.1
128.8
191.4
112.2
99.4
97.2

balance-sheet.row.other-current-assets

630.57156.7171.6120.8
94.8
147.9
94.7
73.6
79.2
81.5
34.9
20
-5
-3.9
-9
-10.7
10
-18.6

balance-sheet.row.total-current-assets

60447.1315630.514995.613285.3
12567.2
11723.4
9682.4
8014
6355.1
4881.1
3614.1
2173
1381.7
1104.7
997.3
531.3
444.8
412.8

balance-sheet.row.property-plant-equipment-net

2752.52679.7735.9850.3
795.5
468.1
330
343.5
353
375.3
378.3
320
321.5
268.5
219.1
154.3
102
102.3

balance-sheet.row.goodwill

1983.55475.9515.9562.4
576.1
652.4
655.8
655.8
475.3
471.9
456.9
100.4
0
0
5.6
5.6
5.6
5.6

balance-sheet.row.intangible-assets

142.7135.635.836.6
31
29.6
31
34.9
38.2
42.2
35.2
33
34
33.6
46.7
48
43.3
53.3

balance-sheet.row.goodwill-and-intangible-assets

2126.27511.4551.7599
607.1
682
686.9
690.7
513.6
514.1
492.1
133.4
34
33.6
52.3
53.6
48.9
58.9

balance-sheet.row.long-term-investments

7.781.72.32.3
9.3
11.7
0
138.3
143.6
105.3
40.4
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

374.339368.152.6
56.4
31.3
21.3
16.8
12.9
10.7
7.3
4
2.1
1.2
1.5
1.1
0.7
1.3

balance-sheet.row.other-non-current-assets

789.85204.4203148.2
98.3
121
129.8
1.2
1.4
0.4
15
158
180.6
170.7
156.9
177
137.9
283.3

balance-sheet.row.total-non-current-assets

6050.751490.315611652.3
1566.6
1314
1167.9
1190.6
1024.5
1005.8
933.1
615.3
538.2
474.1
429.8
386
289.4
445.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

66497.8817120.916556.614937.5
14133.7
13037.4
10850.4
9204.6
7379.6
5886.9
4547.3
2788.4
1919.8
1578.8
1427.2
917.3
734.2
858.5

balance-sheet.row.account-payables

23067.095858.15319.54442.4
4094.5
3914.5
3209.8
2699.6
2377.1
1777.2
1297
1110.8
716.8
427.9
345.2
228.2
163.3
108.8

balance-sheet.row.short-term-debt

14121.283842.740683774.5
3602.7
3463.1
2583
2068.7
1696.6
1503
1055
113
10
0
0
60.6
63
85.5

balance-sheet.row.tax-payables

394.27115.596.899.8
116.1
94.2
101.6
97.5
62.5
49.9
41.6
28.6
13.6
5.6
1.6
2.9
4.3
5.2

balance-sheet.row.long-term-debt-total

781.08175.9208.8229.2
176.1
6.2
746
746
6
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

-4.3-4.300
-37.3
6.2
-740
-740
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

30.66---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

130.8453732.834
41.2
213.4
470.9
93.5
113.9
37.7
9.3
1.7
0.8
26.3
24.7
0.4
0.6
1.4

balance-sheet.row.total-non-current-liabilities

811.74180.2220259.2
213.3
18.1
752.3
752.1
6.2
0.2
0
30.5
36.4
34.3
32.5
49.4
16.2
60.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

781.08175.9208.8229.2
176.1
192.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

42070.4411029.3106359281
8809.7
8114.5
7117.7
6007.4
4444.3
3684.8
2872.7
1485
792.2
488.4
402.5
353.4
259.1
281.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1166.83291.7291.7291.7
291.7
291.7
250.5
250.5
250.5
240
240
240
240
240
160
120
120
120

balance-sheet.row.retained-earnings

9684.42430.62268.12079.1
1858.4
1683.5
1366.1
1095.1
896.3
746.3
609
433.7
343.5
319.6
296.5
264.9
239.6
201.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

3516.490240237.6
200.6
172.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2556.41518.21278.21278.2
1278.2
1278.2
880.7
861.5
834.3
445
438.2
513.1
510.9
499.4
565.5
176.7
113.2
243.2

balance-sheet.row.total-stockholders-equity

16924.124240.540783886.5
3628.9
3425.5
2497.3
2207.2
1981.1
1431.3
1287.2
1186.8
1094.4
1058.9
1022
561.6
472.8
564.2

balance-sheet.row.total-liabilities-and-stockholders-equity

66497.8817120.916556.614937.5
14133.7
13037.4
10850.4
9204.6
7379.6
5886.9
4547.3
2788.4
1919.8
1578.8
1427.2
917.3
734.2
858.5

balance-sheet.row.minority-interest

7503.3218511843.61770
1695.1
1497.3
1235.4
990
954.1
770.7
387.4
116.6
33.2
31.4
2.7
2.3
2.2
13.2

balance-sheet.row.total-equity

24427.446091.55921.65656.6
5324
4922.9
3732.7
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

66497.88---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

8.371.72.42.5
2.5
4.6
2.8
6.4
2.5
2.5
2.4
131.8
157.2
148.9
144.4
159.9
118
258.4

balance-sheet.row.total-debt

14902.364018.74276.84003.8
3778.8
3463.1
3329
2814.7
1696.6
1503
1055
113
10
0
0
60.6
63
85.5

balance-sheet.row.net-debt

4370.41133.22093.21665.6
1760.3
1886.6
2248.9
1690.3
900.6
965.8
605.9
-190.4
-374.4
-512.9
-465.5
-151.9
-113.1
-11.3

Rahavoogude aruanne

Cachet Pharmaceutical Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 4.967 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 1766.32 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -175435670.760. See on -0.318 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 226.75, 3.77, -4619.62, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -282.31 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 4739.09, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

257.86468.3601.9590.9
659.8
570.6
469.4
410
301.3
306.4
146.6
68.9
63.8
48.9
42.5
41.6
183

cash-flows.row.depreciation-and-amortization

168.35226.7201.1175.9
80.8
32.2
30.4
27.7
25.2
22
17.2
12.8
7.5
8.5
8
10.2
9.8

cash-flows.row.deferred-income-tax

0-34.3-3.50.3
1.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

034.33.5-0.3
-1.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-528.8-1216.3-133.8-47.7
-686.4
-1117.1
-1002.2
-423.1
-735.5
-1004.1
-433.1
-123.5
-6.3
-111.8
-1.7
2.3
-66.8

cash-flows.row.account-receivables

-601.58-2437.7-655.1-699
-1125.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

72.78-510.7-179.8183.5
-550
-387.8
-155.1
-240.2
-269.8
-220.8
-223.2
-98.3
62.6
-78.5
-12.8
-4.7
-5.7

cash-flows.row.account-payables

01766.3704.7467.5
987.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-34.3-3.50.3
1.6
-729.3
-847.1
-182.8
-465.7
-783.4
-209.9
-25.2
-68.9
-33.3
11
7
-61.2

cash-flows.row.other-non-cash-items

1271.58357.8243.9395.7
239
222.5
128.3
101.6
98.6
-88.8
-43.1
4.9
-16.5
4.7
1.3
0.7
-190.5

cash-flows.row.net-cash-provided-by-operating-activities

1168.99000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-197.7-188.5-247-258
-262.5
-21.7
-21.3
-38.9
-66.7
-53.6
-23.6
-65.7
-91.8
-65.4
-63.8
-22.2
-8.2

cash-flows.row.acquisitions-net

50.76-1.659.21.4
16.6
0.9
-60.2
0.5
-4.7
-119.8
-12.3
0
74.1
0
0
0
-16.5

cash-flows.row.purchases-of-investments

3.920-16.2-42
-47.6
-23.8
-69.1
-138.1
-156
-10.8
46.1
0
33
0
0
0
-6.6

cash-flows.row.sales-maturities-of-investments

-25.3310.92.31
0.2
2.6
10.6
1.8
1.6
149.7
40.9
2
2
2
41.2
0
210.6

cash-flows.row.other-investing-activites

31.443.8-55.54.1
-25.4
0.3
0.3
1.2
27.9
-24.2
-10.5
0
-7.5
10.3
8
73.2
-41.1

cash-flows.row.net-cash-used-for-investing-activites

-168.68-175.4-257.1-293.5
-318.7
-41.7
-139.7
-173.4
-197.9
-58.8
40.5
-63.7
9.8
-53.2
-14.6
51
138.2

cash-flows.row.debt-repayment

-3431.74-4619.6-3975.2-4948.4
-4905.5
-2933.5
-2106.6
-2153
-1625
-102.2
-31
0
-3
-133.6
-63
-106
-45

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-207.44-282.3-242.7-289.1
-250.2
-223.7
-121.4
-131.5
-105.6
-99.6
-32.8
-36
-34.3
-16.4
-16.4
-3.4
-8.8

cash-flows.row.other-financing-activites

1938.414739.13884.84864
5671.8
3444.1
2933
2600.4
2337.5
1199.8
215
8.1
26.3
505.8
70.3
92.9
16.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-753.17-162.8-333.1-373.5
516.1
286.9
705
315.9
606.9
998
151.2
-27.9
-11
355.8
-9.1
-16.5
-37.5

cash-flows.row.effect-of-forex-changes-on-cash

00-0.7-0.4
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

247.14-501.7322.2447.4
490.6
-46.5
191.2
258.8
98.7
174.8
-120.7
-128.5
47.4
253
26.3
89.4
36.2

cash-flows.row.cash-at-end-of-period

8914.641699.322011878.8
1431.4
940.8
987.3
796
537.2
438.5
263.7
384.4
512.9
465.5
212.5
186.1
96.8

cash-flows.row.cash-at-beginning-of-period

8667.522011878.81431.4
940.8
987.3
796
537.2
438.5
263.7
384.4
512.9
465.5
212.5
186.1
96.8
60.6

cash-flows.row.operating-cash-flow

1168.99-163.4913.11114.9
293.1
-291.8
-374
116.3
-310.3
-764.5
-312.4
-36.9
48.6
-49.6
50.1
54.8
-64.5

cash-flows.row.capital-expenditure

-197.7-188.5-247-258
-262.5
-21.7
-21.3
-38.9
-66.7
-53.6
-23.6
-65.7
-91.8
-65.4
-63.8
-22.2
-8.2

cash-flows.row.free-cash-flow

971.3-352666.2856.9
30.6
-313.4
-395.3
77.4
-377.1
-818.1
-336
-102.6
-43.2
-115
-13.7
32.6
-72.8

Kasumiaruande rida

Cachet Pharmaceutical Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.144%. 002462.SZ brutokasum on teatatud 1977.71. Ettevõtte tegevuskulud on 1072.05, mille muutus võrreldes eelmise aastaga on -7.743%. Kulud amortisatsioonikulud on 226.75, mis on -0.109% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 1072.05, mis näitab -7.743% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.406% kasvu võrreldes eelmise aastaga. Tegevustulu on 556.36, mis näitab -0.406% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.466%. Eelmise aasta puhaskasum oli 250.06.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

30683.1429996.226219.825625.6
23256.1
22186.6
17959.9
14238.9
10971.6
8199.8
5572.2
3544.3
2554.1
1801.4
1341.7
1133.6
965.2
662.9

income-statement-row.row.cost-of-revenue

28755.6728018.524112.223484.9
21122
19916.2
16122.3
12858.2
9774.4
7146.7
4854.2
3206.9
2332
1630.6
1171.5
980.7
829.4
555.7

income-statement-row.row.gross-profit

1927.461977.72107.62140.8
2134.2
2270.4
1837.6
1380.7
1197.2
1053.1
717.9
337.4
222.1
170.7
170.2
152.9
135.8
107.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

61.72---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

678.23---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-0.53-12263.7234.2
192.8
196.5
-2.3
-2.5
7
4
4
29.6
-0.1
15.7
-0.4
0.1
4.6
2.9

income-statement-row.row.operating-expenses

1023.971072.111621103.7
933.4
1157.2
859.1
638.7
563.4
562.7
403.7
196.1
134.7
110.6
106.2
96.3
85.6
88.6

income-statement-row.row.cost-and-expenses

29779.6529090.625274.324588.6
22055.4
21073.4
16981.4
13496.9
10337.8
7709.4
5257.9
3403
2466.7
1741.2
1277.8
1076.9
915
644.3

income-statement-row.row.interest-income

189.4531.1-22.417.1
20.2
13.9
13.3
6.1
2.6
3.3
2.4
2.9
6.1
7.6
4.1
0
0
0

income-statement-row.row.interest-expense

73.91155.4175.3164.2
180.8
191.9
190.1
110.4
81
78.6
31
2.2
0.1
0
2.3
0.4
1.7
0.8

income-statement-row.row.selling-and-marketing-expenses

678.23---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-217.24-350.4-292-6.8
-380.6
-3.6
-203.7
-112.9
-81.6
-87.4
96.2
53
4.2
25.3
0.9
-0.2
5
196.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-0.53-12263.7234.2
192.8
196.5
-2.3
-2.5
7
4
4
29.6
-0.1
15.7
-0.4
0.1
4.6
2.9

income-statement-row.row.total-operating-expenses

-217.24-350.4-292-6.8
-380.6
-3.6
-203.7
-112.9
-81.6
-87.4
96.2
53
4.2
25.3
0.9
-0.2
5
196.5

income-statement-row.row.interest-expense

73.91155.4175.3164.2
180.8
191.9
190.1
110.4
81
78.6
31
2.2
0.1
0
2.3
0.4
1.7
0.8

income-statement-row.row.depreciation-and-amortization

281.99202.1226.7408.3
175.9
304.2
32.2
30.4
27.7
25.2
22
17.2
12.8
7.5
8.5
8
10.2
9.8

income-statement-row.row.ebitda-caps

904.8---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

573.55556.4936.9830.8
1194.9
891.1
777.2
631.6
545.3
399.1
406.5
164.7
91.7
69.7
65.3
56.4
50.7
212.3

income-statement-row.row.income-before-tax

583.96555.3644.9824
814.3
887.5
774.9
629.1
552.2
403
410.5
194.3
91.5
85.4
64.8
56.5
55.3
215.1

income-statement-row.row.income-tax-expense

187.67178.7176.6222.1
223.4
227.7
204.2
159.6
142.2
101.7
104.1
47.6
22.7
21.6
15.9
13.9
13.7
32.1

income-statement-row.row.net-income

257.86250.1468.3601.9
590.9
659.8
327.6
263.6
223.1
173
228.1
130.2
65.2
63.7
48.5
42.4
41.4
182.6
Sarnased aktsiad
Sind võib huvitada ka:
NEU.WA
NEUCA S.A..
892 PLN
WSE
3390.HK
Tycoon Group Holdings Limited.
4 HKD
HKSE
8095.T
Astena Holdings Co., Ltd..
485 JPY
JPX
FSPM
FusionPharm, Inc..
0.0001 USD
PNK
2796.T
Pharmarise Holdings Corporation.
659 JPY
JPX
600833.SS
Shanghai No.1 Pharmacy Co., Ltd..
10.69 CNY
SHH
OKDAV.HE
Oriola Oyj.
1.11 EUR
HEL
LFLY
Leafly Holdings, Inc..
2.96 USD
NASDAQ
LFMD
LifeMD, Inc..
10.18 USD
NASDAQ
KNB.L
Kanabo Group Plc.
1.75 GBp
LSE

Korduma kippuv küsimus

Mis on Cachet Pharmaceutical Co., Ltd. (002462.SZ) koguvara?

Cachet Pharmaceutical Co., Ltd. (002462.SZ) koguvara on 17120851592.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 15651563096.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.063.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 3.329.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.008.

Mis on ettevõtte kogutulu?

Kogutulu on 0.019.

Mis on Cachet Pharmaceutical Co., Ltd. (002462.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 250060041.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 4018688843.000.

Mis on tegevuskulude arv?

Tegevuskulud on 1072054997.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 2853572169.000.